Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate whether the administration of allodepleted donor T cells to patients with haematological malignancies after stem cell transplant can improve the recovery of the patients immune system.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01827579
Study type Interventional
Source University College, London
Contact
Status Completed
Phase Phase 1/Phase 2
Start date July 2014
Completion date January 2020

See also
  Status Clinical Trial Phase
Recruiting NCT01719341 - Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia N/A
Terminated NCT04865419 - Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies Phase 1/Phase 2
Suspended NCT02988258 - Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT Phase 1
Completed NCT05148806 - Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies
Terminated NCT01080664 - A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies Phase 1
Withdrawn NCT01336478 - CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation Phase 1